Latest Tax News

Chimeric Therapeutics has stopped enrolment and dosing in its CHM-2101 CAR-T trial after a safety review found the highest dose unsafe. With $1.35 million in cash, suspended securities and uncertain creditor negotiations, the company is now pursuing a possible recapitalisation while preserving a preclinical CDH17 pathway.

Impact Minerals is recasting itself as a high-purity alumina developer, with Lake Hope advancing towards a definitive feasibility study and Alluminous reaching pilot-plant milestones. But the annual report also flags a material uncertainty over funding, while a board refresh and managing director departure add to the company’s transition.

Western Gold Resources has lifted Gold Duke’s Production Target by 62% to 59.7koz of contained gold, strengthening the project’s development case. But the company still needs a processing solution and reports only about 1.56 quarters of funding on current outgoings.

Dateline Resources has a funded but halted California gold project after a preliminary injunction suspended Colosseum activities, just as the company completed engineering and advanced financing. Its September quarter also delivered rare earth results of up to 7.13% TREO at Music Valley, but cash fell to A$70.2 million and the reported runway was about 4.2 quarters.

Global Lithium’s September quarter combined a recommended A$333 million cash takeover with a sharply improved development case for its Manna lithium project. The proposed Titan deal remains conditional, while the new study’s strong returns depend on lithium prices, exchange rates and execution.

Mindax ended FY2026 with just A$83,116 in cash and a A$2.49 million loss before tax, prompting its auditor to highlight material uncertainty over the company’s ability to continue as a going concern. Post-year-end funding has lifted cash to A$4.079 million, although much of that support remains tied to convertible debt and approvals.

Knosys has moved its Libero library platform into active US commercialisation, identifying near-term sales opportunities while preparing for its first customer engagements. The push comes as ARR slips to A$8.7 million and a timing-affected quarter leaves the company with 2.03 quarters of estimated funding.

Hammer Metals has reported a A$2.20 million FY2026 loss as its proposed Austral Resources takeover moves towards shareholder and court approval. The annual report also highlights strong Kalman drilling, but flags a material funding uncertainty if the transaction does not proceed.

Tissue Repair has increased its US Phase III chronic wound trial to approximately 112 randomised patients while shifting focus towards an April 2027 FDA 510(k) submission. The company also reported $4.74 million in cash, Australian availability of all three TR Pro+ formats and a planned $1 million share buy-back.

Gowing Bros has reported a $3.49 million FY2026 net loss, with Surf Hardware International remaining deeply loss-making and shopping centre values falling by $3 million. The diversified investment group maintained a fully franked 3 cents per share final dividend as cash declined and borrowings increased.

Transmetro Corporation (ASX:TCO) delivered a 50% increase in FY2026 net profit to A$4.49 million, while cash rose to A$13.94 million and the fully franked dividend increased to 6 cents per share. The debt-free hotel operator is preparing to open Metro Hotel Martin Place Sydney and support a major refurbishment of its 220-room Marlow property.

Xref reported A$4.7 million of unaudited Q1 FY2027 revenue and positive EBITDA of A$0.6 million, as its newer platform generated 48% revenue growth. Trust Marketplace checks, Pulse surveys and employee lifecycle products all recorded sharp increases, while stronger liquidity is supporting renewed marketing investment.